circRNA basic information
circBase ID: hsa_circ_0119412
Name: -
Synonym: circ_0119412
Host Gene: -
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0002974
MONDO name: cervical cancer
Disease details: cervical cancer
Disease DO ID:
4362
Disease MeSH ID:
-
Disease NCIt ID:
C9311
Disease ICD11 ID:
1256072522
Disease OMIM ID:
603956
Species: Human
Species details: Homo sapiens
Tissue specimen:

cervical tumor tissues; matched nontumor normal tissues

Cell lines:

HcerEpic; CaSki; Hela; SiHa; C33A

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: AGR2
Associated microRNA: miR-217
Biological function: promotes cervical cancer cell proliferation, migration, adhesion, tumor formation and tumor growth
Molecular mechanism: circ_0119412 acts as a ceRNA by targeting/sequestering miR-217 to relieve miR-217-mediated inhibition of AGR2, thereby upregulating AGR2 and promoting cervical cancer progression
Biological pathway or process:

proliferation (promotes); migration (promotes); ceRNA regulation (promotes); other pathway/process (promotes)

Detected method:
Q
Validation methods:

RNase R Treatment; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; MTT; Transwell Assay; In Vivo Animal Model; Western Blot; Bioinformatics Analysis

Clinical significance:

targeted inhibition of circ_0119412 might be a therapeutic strategy for cervical cancer

Description:

hsa_circ_0119412/circ_0119412 is up-regulated in cervical cancer tissues and cell lines. It promotes cervical cancer cell proliferation, migration, adhesion and xenograft tumor growth by sequestering miR-217 and relieving inhibition of AGR2. The study suggests that targeting circ_0119412 may have therapeutic potential in cervical cancer.

Confidence score:

0.7795

Other information
Title:

hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2.

Journal: Journal of clinical laboratory analysis
Published: 2022
PubMed ID: 35274779
Study type:

combined biological and clinical study

Data availability: GSE64217; GSE89657; available from the corresponding author on reasonable request
Code availability: -